Sympathoinhibitory signals from the gut and obesity-related hypertension

被引:0
|
作者
Daniela M. Sartor
机构
[1] University of Melbourne,Clinical Pharmacology and Therapeutics Unit, Department of Medicine
[2] Austin Health,undefined
来源
关键词
Sympathetic nervous system; Cholecystokinin; Leptin; Obesity; Hypertension; Cardiovascular;
D O I
暂无
中图分类号
学科分类号
摘要
Several gastrointestinal hormones are commonly associated with satiety and digestion, but recent studies suggest they are also involved in regulating hemodynamic demand after a meal. These hormones released from the gut postprandially play a role in short-term cardiovascular regulation via a vagally mediated sympathoinhibitory reflex mechanism, similar to that of the arterial baroreflex. It has been hypothesized that activation of this reflex may promote greater blood flow to the splanchnic and renal vasculature that have increased haemodynamic demand after a meal, while simultaneously inducing vasoconstriction to the skeletomuscular vasculature where it is needed less. Together, the renal and splanchnic circulations can command over 50 % of cardiac output so that the role of gut hormones in controlling sympathetic vasomotor tone to these vascular beds may be more important in cardiovascular regulation than previously thought. The exact aetiology of obesity-related hypertension remains to be determined and is likely to be multifactorial, although the involvement of gut hormone signalling in the development of this disease has not previously been considered. Diets rich in fats and increased food intake are amongst the leading causes of obesity and precipitate significant changes such as inflammation in the gastrointestinal environment that can lead to blunted vagal afferent signalling. In obesity, these changes may disrupt sympathoinhibitory mechanisms and subsequently lead to increased vascular resistance in the gastrointestinal and renal vascular beds, contributing to the development of hypertension.
引用
收藏
页码:33 / 39
页数:6
相关论文
共 50 条
  • [21] Factors Responsible for Obesity-Related Hypertension
    Kyungjoon Lim
    Kristy L. Jackson
    Yusuke Sata
    Geoffrey A. Head
    [J]. Current Hypertension Reports, 2017, 19
  • [22] Factors Responsible for Obesity-Related Hypertension
    Lim, Kyungjoon
    Jackson, Kristy L.
    Sata, Yusuke
    Head, Geoffrey A.
    [J]. CURRENT HYPERTENSION REPORTS, 2017, 19 (07)
  • [23] IS THERE A TRANSIENT, OBESITY-RELATED HYPERTENSION OF ADOLESCENCE
    STICKLER, GB
    [J]. CLINICAL PEDIATRICS, 1986, 25 (11) : 573 - 574
  • [24] Role of leptin in obesity-related hypertension
    Aizawa-Abe, M
    Ogawa, Y
    Masuzaki, H
    Ebihara, K
    Shintani, M
    Miyanaga, F
    Nakao, K
    [J]. JOURNAL OF HYPERTENSION, 2000, 18 : S120 - S120
  • [25] Treatment strategies for obesity-related hypertension
    Efrain Reisin
    [J]. Current Hypertension Reports, 2008, 10 : 129 - 130
  • [26] Role of leptin in obesity-related hypertension
    Haynes, WG
    [J]. EXPERIMENTAL PHYSIOLOGY, 2005, 90 (05) : 683 - 688
  • [27] The Role of Aldosterone in Obesity-Related Hypertension
    Kawarazaki, Wakako
    Fujita, Toshiro
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2016, 29 (04) : 415 - 423
  • [28] Adipocytes, aldosterone and obesity-related hypertension
    Cat, Aurelie Nguyen Dinh
    Friederich-Persson, Malou
    White, Anna
    Touyz, Rhian M.
    [J]. JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2016, 57 (01) : F7 - F21
  • [29] Fishing for obesity-related gut microbiome enterotype
    Rao, Xuechen
    Shao, Yikai
    Wu, Hao
    [J]. CELL HOST & MICROBE, 2024, 32 (08) : 1209 - 1211
  • [30] Gut microbiome: Microflora association with obesity and obesity-related comorbidities
    Lone, Jameel Barkat
    Koh, Wee Yin
    Parray, Hilal A.
    Paek, Woon K.
    Lim, Jeongheui
    Rather, Irfan A.
    Jan, Arif Tasleem
    [J]. MICROBIAL PATHOGENESIS, 2018, 124 : 266 - 271